alkannin has been researched along with 1-methylpropyl-2-imidazolyl disulfide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, F; Deng, Y; Du, X; Duan, Y; Guddat, LW; Jiang, H; Jiang, R; Jin, Z; Li, X; Liu, F; Liu, H; Liu, M; Liu, X; Peng, C; Qin, C; Rao, Z; Shi, Z; Wang, L; Xiao, G; Xu, W; Xu, Y; Yang, H; Yang, K; Yang, X; You, T; Yu, J; Zhang, B; Zhang, L; Zhao, Y | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
2 other study(ies) available for alkannin and 1-methylpropyl-2-imidazolyl disulfide
| Article | Year |
|---|---|
Structure of M
Topics: Antiviral Agents; Betacoronavirus; Cells, Cultured; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Humans; Models, Molecular; Pandemics; Pneumonia, Viral; Protease Inhibitors; Protein Structure, Tertiary; SARS-CoV-2; Viral Nonstructural Proteins | 2020 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |